BIO Bio-Rad Laboratories PE ratio, current and historical analysis
- Stocks
- Healthcare
- NYSE: BIO
- PE Ratio
The current PE ratio of BIO cannot be calculated, as the latest EPS of -$76.07 is negative. The most recent PE ratio recorded for Bio-Rad Laboratories was 5.3 in December 2021.
BIO PE ratio history
Over the last ten years, the average PE ratio of Bio-Rad Laboratories has been 66.95. Looking back at the last ten years, BIO's PE ratio peaked in the Jun 2017 quarter at 514.34, with a price of $226.31 and an EPS of $0.44. The Sep 2021 quarter marked the lowest point at 3.34, with a price of $745.95 and an EPS of $223.61.
Bio-Rad Laboratories PE ratio by year
Maximum annual increase: 458.78% in 2016
Maximum annual decrease: -72.03% in 2017
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2024 | N/A | N/A | $328.51 | -$65.36 |
| 2023 | N/A | N/A | $322.89 | -$21.82 |
| 2022 | N/A | N/A | $420.49 | -$121.79 |
| 2021 | 5.3 | 16.48% | $755.57 | $142.61 |
| 2020 | 4.55 | -27.55% | $582.94 | $128.13 |
| 2019 | 6.28 | -66.88% | $370.03 | $58.93 |
| 2018 | 18.96 | -67.27% | $232.22 | $12.25 |
| 2017 | 57.93 | -72.03% | $238.67 | $4.12 |
| 2016 | 207.14 | 458.78% | $182.28 | $0.88 |
| 2015 | 37.07 | -5.29% | $138.66 | $3.74 |
| 2014 | 39.14 | -13.86% | $120.56 | $3.08 |
| 2013 | 45.44 | 153.01% | $123.61 | $2.72 |
| 2012 | 17.96 | 19.49% | $105.05 | $5.85 |
| 2011 | 15.03 | -3.03% | $96.04 | $6.39 |
| 2010 | 15.5 | -15.16% | $103.85 | $6.7 |
Bio-Rad Laboratories PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Mar 2025 | N/A | N/A | $243.56 | -$76.07 |
| Dec 2024 | N/A | N/A | $328.51 | -$65.36 |
| Sep 2024 | N/A | N/A | $334.58 | -$27.62 |
| Jun 2024 | N/A | N/A | $273.11 | -$47.34 |
| Mar 2024 | N/A | N/A | $345.87 | -$10.67 |
| Dec 2023 | N/A | N/A | $322.89 | -$21.82 |
| Sep 2023 | N/A | N/A | $358.45 | -$5.99 |
| Jun 2023 | N/A | N/A | $379.12 | -$15.12 |
| Mar 2023 | N/A | N/A | $479.02 | -$6.58 |
| Dec 2022 | N/A | N/A | $420.49 | -$121.79 |
| Sep 2022 | N/A | N/A | $417.14 | -$201.71 |
| Jun 2022 | N/A | N/A | $495 | -$64.48 |
| Mar 2022 | N/A | N/A | $563.23 | -$2.72 |
| Dec 2021 | 5.3 | 58.68% | $755.57 | $142.61 |
| Sep 2021 | 3.34 | -29.39% | $745.95 | $223.61 |
BIO Price vs fair value
BIO average PE ratio chart
BIO PE vs peers
| Stock name | PE ratio | Market cap |
|---|---|---|
| JNJ Johnson & Johnson | 16.18 | $352.61B |
| TMO Thermo Fisher Scientific Inc | 24.27 | $156.55B |
| A Agilent Technologies Inc | 25.78 | $32.12B |
| BDX Becton Dickinson & Co | 33.25 | $49.37B |
| GE General Electric Co | 34.22 | $236.44B |
| DHR Danaher Corp | 36.85 | $136.86B |
| HBIO Harvard Bioscience Inc | N/A | $15.53M |
| BIO Bio-Rad Laboratories Inc | N/A | $6.59B |
Frequently asked questions
What is Bio-Rad Laboratories's PE ratio?
The current price to earnings ratio of BIO cannot be determined, as its EPS of -$76.07 is negative.
What is the 5-year average PE ratio for Bio-Rad Laboratories (BIO)?
As an average over the last 5 years, BIO stock has a PE ratio of 4.76.
What is the highest PE ratio for BIO?
The highest quarterly PE ratio in the last ten years has been 514.34 and it was in the Jun 2017 quarter.
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.